Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Mol Med ; 19(9): 2193-201, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26033571

ABSTRACT

The glycolipid glycosylphosphatidylinositol anchor (GPI-A) plays an important role in lipid raft formation, which is required for proper expression on the cell surface of two inhibitors of the complement cascade, CD55 and CD59. The absence of these markers from the surface of blood cells, including erythrocytes, makes the cells susceptible to complement lysis, as seen in patients suffering from paroxysmal nocturnal haemoglobinuria (PNH). However, the explanation for why PNH-affected hematopoietic stem/progenitor cells (HSPCs) expand over time in BM is still unclear. Here, we propose an explanation for this phenomenon and provide evidence that a defect in lipid raft formation in HSPCs leads to defective CXCR4- and VLA-4-mediated retention of these cells in BM. In support of this possibility, BM-isolated CD34(+) cells from PNH patients show a defect in the incorporation of CXCR4 and VLA-4 into membrane lipid rafts, respond weakly to SDF-1 stimulation, and show defective adhesion to fibronectin. Similar data were obtained with the GPI-A(-) Jurkat cell line. Moreover, we also report that chimeric mice transplanted with CD55(-/-)  CD59(-/-) BM cells but with proper GPI-A expression do not expand over time in transplanted hosts. On the basis of these findings, we propose that a defect in lipid raft formation in PNH-mutated HSPCs makes these cells more mobile, so that they expand and out-compete normal HSPCs from their BM niches over time.


Subject(s)
Hemoglobinuria, Paroxysmal/metabolism , Hemoglobinuria, Paroxysmal/pathology , Membrane Microdomains/metabolism , Animals , Antigens, CD/metabolism , Bacterial Toxins/metabolism , Bone Marrow/pathology , Cell Adhesion/drug effects , Chemokine CXCL12/pharmacology , Chemotaxis/drug effects , Fibronectins/metabolism , Glycosylphosphatidylinositols/metabolism , Humans , Integrin alpha4beta1/metabolism , Jurkat Cells , Membrane Microdomains/drug effects , Mice, Inbred C57BL , Pore Forming Cytotoxic Proteins/metabolism , Receptors, CXCR4/metabolism , Signal Transduction/drug effects
2.
Hum Mutat ; 36(9): 831-5, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26096313

ABSTRACT

Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by a distinctive mid-hindbrain malformation. JS is part of a group of disorders called ciliopathies based on their overlapping phenotypes and common underlying pathophysiology linked to primary cilium dysfunction. Biallelic mutations in one of 28 genes, all encoding proteins localizing to the primary cilium or basal body, can cause JS. Despite this large number of genes, the genetic cause can currently be determined in about 62% of individuals with JS. To identify novel JS genes, we performed whole exome sequencing on 35 individuals with JS and found biallelic rare deleterious variants (RDVs) in KIAA0586, encoding a centrosomal protein required for ciliogenesis, in one individual. Targeted next-generation sequencing in a large JS cohort identified biallelic RDVs in eight additional families for an estimated prevalence of 2.5% (9/366 JS families). All affected individuals displayed JS phenotypes toward the mild end of the spectrum.


Subject(s)
Cell Cycle Proteins/genetics , Cerebellum/abnormalities , Mutation , Retina/abnormalities , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Adolescent , Adult , Alternative Splicing , Brain/pathology , Child , Child, Preschool , DNA Mutational Analysis , Eye Abnormalities/diagnosis , Eye Abnormalities/genetics , Gene Order , Genetic Association Studies , Humans , Kidney Diseases, Cystic/diagnosis , Kidney Diseases, Cystic/genetics , Magnetic Resonance Imaging , Phenotype , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...